AlbertazziA., PalmieriP. F., SpiniC., Di GuglielmoR., PolidoroM. M.: Modificazioni dell'equilibrio idro-elettrolitico dopo somministrazione di acqua oliminerale in pazienti nefrolitiasici. Clinica Terap. (1985).
2.
BreslauN. A., PakC. Y. C.: Urinary saturation, heterogeneous nucleation and crystallization inhibitors in nephrolithiasis. In: CoeF. L., BrennerB. M., StainJ. H. (eds.): Nephrolithiasis, p. 116–135. Churchill Livingstone, New York 1980.
3.
CoeF. L.: Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria hyperuricosuria or no metabolic disorder. Ann. Intern. Med., 87; 404–408 (1977).
4.
CostanzoL. S., WindhagerE. E.: In vivo microperfusion study of calcium (Ca) and sodium (Na) transport in the distal convoluted tubule. Kidney intern., 12; 456–462 (1977).
5.
FleischH.: Inhibitors and promoters of stone-formation. Kidney intern., 13; 361–372 (1978).
6.
HerringL. C.: Observations on the analysis of ten thousand urinary calculi. J. Urol., 88; 545–561 (1962).
7.
HiattR.A., FriedmanG.D.: The frequency of kidney and urinary tract diseases in a defined population. Kidney intern., 22; 63–68 (1982).
8.
HillsA. G., ParsonsD. W., WebsterG. D.jr.: Influence of the renal excretion of sodium chloride upon the renal excretion of magnesium and other ions by human subjects. J. Clin. Endocrinol. Metab., 18; 1192–1211 (1959).
9.
HoskingD. H., EricksonS. B., van den BergC. J.: The stone clinic effect in patients with idiopathic calcium urolithiasis. J. Urol., 130; 1115–1118 (1983).
10.
MalagodiM. H., MoyeH. A.: Physical and chemical characteristics of renal stone matrix. Urol. Survey, 31; 87–91 (1981).
11.
MeyerW. J.III, TransbolI., BartterF. C.: Control of calcium absorption: effect of sodium chloride loading and depletion. Metabolism, 25; 989–993 (1976).
12.
ModlinM.: The interrelation of urinary calcium and sodium in normal adults. Invest. Urol., 4; 180–189 (1966).
13.
PakC. Y. C., BrittonF., PetersonR.: Ambulatory evaluation of nephrolithiasis: Classification, clinical presentation and diagnostic criteria. Amer. J. Med., 69; 19–30 (1980).
14.
PakC. Y. C., SakhaeeK., Crowther: Evidence justifying a high fluid intake in treatment of nephrolithisais. Ann. Intern. Med., 93; 36–39 (1980).
15.
PeacockM., RobertsonW. G.: Treatment of urinary tract stone disease. Drugs, 20; 225–232 (1980).
16.
RandallA.: The etiology of primary renal calculus. Intern. Abstr. Surg., 71; 209–240 (1940).
17.
SchollzD., SchwilleP. O., SigelA.: Double-blind study with thiazide in recurrent calcium lithiasis. J. Urol., 128; 903–907 (1982).
18.
SierakowskiR., HempG., FinlaysonB.: Water hardness and the incidence of urinary calculi. Colloquium on renal lithiasis. University Press of Florida, 1976.
19.
StraussA. L., CoeF. L., DeutschL.: Factors that predict relapse of calcium nephrolithiasis during treatment: A prospective study. Amer. J. Med., 72; 17–24 (1982).
20.
ThomasW. C.jr.: Medical aspects of renal calcolous disease: treatment and prophylaxis. Urol. Clin. N. Amer., 1; 261–265 (1974).
21.
WilliamsR. E.: Long-term survey of 538 patients with upper urinary tract stone. Brit. J. Urol., 35; 416–437 (1963).
22.
YendtE. R., CohanimM.: Prevention of calcium stones with thiazides. Kidney intern., 13; 397–409 (1978).
23.
ZerweckJ. E., HoltK., PakC. Y. C.: Natural urinary macromulecolar inhibitors: Attenuation of inhibitory activity by urate salts. Kidney intern., 23; 838–841 (1983).